MedCity Influencers From Scarcity to Possibility: What Perfusion Technologies Mean for the Organ Transplantation Industry By Christoffer Rosenblad
Events, Artificial Intelligence Your Guide to the Hottest Topics on AI in Healthcare in Dallas Next Week at INVEST Digital Health By Stephanie Baum
BioPharma, Pharma Gilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition By Frank Vinluan
BioPharma, Pharma AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma By Frank Vinluan
MedCity Influencers Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s By Ricky Bloomfield
MedCity Influencers The Connected Patient Experience: 3 Tips to Empower Healthcare Delivery Through Innovation By Luiz Cieslak
Events Navigating the AI in Healthcare Landscape and Its Future: A Preview of INVEST Digital Health 2025 By Stephanie Baum
MedCity Influencers Telehealth Fraud & Compliance: Preventing ‘Pill Mills’ While Ensuring Access to Care By Josh Rosaasen
BioPharma, Pharma BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs By Frank Vinluan
